![Long-Term Effects of Risperidone in Children With Autism Spectrum Disorders: A Placebo Discontinuation Study - ScienceDirect Long-Term Effects of Risperidone in Children With Autism Spectrum Disorders: A Placebo Discontinuation Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0890856709622164-gr1.gif)
Long-Term Effects of Risperidone in Children With Autism Spectrum Disorders: A Placebo Discontinuation Study - ScienceDirect
![Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study | Scientific Reports Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep34287/MediaObjects/41598_2016_Article_BFsrep34287_Fig1_HTML.jpg)
Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study | Scientific Reports
![Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.2007.164.7.1050/asset/images/medium/r915f1.jpeg)
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry
![Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41537-020-00127-y/MediaObjects/41537_2020_127_Fig1_HTML.png)
Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia
![RISPERDAL CONSTA® - Efficacy of RISPERDAL CONSTA® in the Treatment of Schizophrenia — RISPERDAL CONSTA® (risperidone) LONG-ACTING INJECTION RISPERDAL CONSTA® - Efficacy of RISPERDAL CONSTA® in the Treatment of Schizophrenia — RISPERDAL CONSTA® (risperidone) LONG-ACTING INJECTION](https://www.risperdalconstahcp.com/sites/all/themes/hcpportal-theme/images/imgs/risperdal/img-efficacy-20.png)